重视 PAH 早期发现
及早启动靶向药物
首篇亚洲人群荟萃分析
西地那非 20mg 兼顾疗效和安全性
合理选择西地那非剂量
满足个体化需求
小结
[1]. 中国肺高血压诊断和治疗指南2018.中华心血管病杂志.2018,46(12):933-964.
[2]. Jing ZC, Xu XQ, Han ZY, et al. Registry and survival study in Chinese patients with idiopathic and familial pulmonary arterial hypertension[J]. Chest, 2007, 132(2): 373-379. DOI: 10.1378/chest.06⁃2913.
[3]. Zhang R, Dai LZ, Xie WP, et al. Survival of Chinese patients with pulmonary arterial hypertension in the modern treatment era [J]. Chest, 2011,140(2):301⁃309. DOI: 10.1378/chest.10⁃2327.
[4]. Vazquez ZGS, Klinger JR. Guidelines for the Treatment of Pulmonary Arterial Hypertension. Lung. 2020 Aug;198(4):581-596. doi: 10.1007/s00408-020-00375-w. Epub 2020 Jul 15. PMID: 32671468.
[5]. Bhatia S, Frantz RP, Severson CJ, Durst LA, McGoon MD. Immediate and long-term hemodynamic and clinical effects of sildenafil in patients with pulmonary arterial hypertension receiving vasodilator therapy. Mayo Clin Proc. 2003;78(10):1207-1213. doi:10.4065/78.10.1207
[6]. Seftel AD. Phosphodiesterase type 5 inhibitor differentiation based on selectivity, pharmacokinetic, and efficacy profiles. Clin Cardiol. 2004;27(4 Suppl 1):I14-I19. doi:10.1002/clc.4960271305
[7]. Shi Q, Wang Z, Yang N, et al. Sildenafil for adult Asian patients with pulmonary arterial hypertension: a systematic review and meta-analysis. Ann Palliat Med. 2022 Jan;11(1):339-351.
[8]. Pepke-Zaba J, Gilbert C, Collings L, Brown MC. Sildenafil improves health-related quality of life in patients with pulmonary arterial hypertension. Chest. 2008;133(1):183-189. doi:10.1378/chest.07-0592
来源 | 网络
联系客服